Catherine Harrington

1.4k total citations
24 papers, 911 citations indexed

About

Catherine Harrington is a scholar working on Surgery, General Health Professions and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Catherine Harrington has authored 24 papers receiving a total of 911 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in General Health Professions and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Catherine Harrington's work include Pharmaceutical industry and healthcare (3 papers), Healthcare Policy and Management (3 papers) and Diabetes Treatment and Management (3 papers). Catherine Harrington is often cited by papers focused on Pharmaceutical industry and healthcare (3 papers), Healthcare Policy and Management (3 papers) and Diabetes Treatment and Management (3 papers). Catherine Harrington collaborates with scholars based in United States, Lebanon and Saudi Arabia. Catherine Harrington's co-authors include Adil Moiduddin, Jeremy A. Greene, Robert J. Rubin, Anna K. Poon, Martin Zagari, Devada Singh‐Franco, Nile M. Khanfar, Alexandra Pérez, Jennifer E. Thomas and Joshua Caballero and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetes Care and Emerging infectious diseases.

In The Last Decade

Catherine Harrington

24 papers receiving 838 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine Harrington United States 11 251 229 195 157 150 24 911
Sarah Ramsay United States 15 47 0.2× 62 0.3× 121 0.6× 88 0.6× 38 0.3× 132 826
Aimin Wang China 23 75 0.3× 118 0.5× 109 0.6× 165 1.1× 10 0.1× 82 1.3k
Xing J. Lee Australia 14 19 0.1× 40 0.2× 47 0.2× 81 0.5× 46 0.3× 39 558
Mary E. Walker United States 20 97 0.4× 314 1.4× 14 0.1× 201 1.3× 5 0.0× 63 1.5k
Linda Cowan United States 14 151 0.6× 9 0.0× 271 1.4× 151 1.0× 285 1.9× 36 691
Laura Martinengo Singapore 12 146 0.6× 12 0.1× 383 2.0× 190 1.2× 222 1.5× 22 903
Soma Wali United States 10 147 0.6× 25 0.1× 50 0.3× 98 0.6× 22 0.1× 36 563
Friedrich Hofmann Germany 15 28 0.1× 151 0.7× 5 0.0× 67 0.4× 43 0.3× 52 826
Pieter Stolk Netherlands 20 54 0.2× 25 0.1× 177 0.9× 122 0.8× 10 0.1× 59 1.1k

Countries citing papers authored by Catherine Harrington

Since Specialization
Citations

This map shows the geographic impact of Catherine Harrington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Harrington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Harrington more than expected).

Fields of papers citing papers by Catherine Harrington

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Harrington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Harrington. The network helps show where Catherine Harrington may publish in the future.

Co-authorship network of co-authors of Catherine Harrington

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Harrington. A scholar is included among the top collaborators of Catherine Harrington based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Harrington. Catherine Harrington is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thomas, Jennifer E., et al.. (2024). Acute Adverse Effects of Therapeutic Doses of Psilocybin. JAMA Network Open. 7(4). e245960–e245960. 24 indexed citations
2.
Khanfar, Nile M., et al.. (2022). Considerations of management and marketing courses within pharmacy curricula in the United States. Currents in Pharmacy Teaching and Learning. 14(11). 1348–1352. 2 indexed citations
3.
Caballero, Joshua, et al.. (2021). Neurotoxicities in the treatment of HIV between dolutegravir, rilpivirine and dolutegravir/rilpivirine: a meta-analysis. Sexually Transmitted Infections. 97(4). 261–267. 15 indexed citations
4.
5.
Mitroka, James, Catherine Harrington, & Matthew J. DellaVecchia. (2019). A multiyear comparison of flipped- vs. lecture-based teaching on student success in a pharmaceutical science class. Currents in Pharmacy Teaching and Learning. 12(1). 84–87. 6 indexed citations
6.
Almasri, Diena M., et al.. (2017). The association of vitamin D deficiency and glucose control among diabetic patients. Saudi Pharmaceutical Journal. 25(8). 1179–1183. 12 indexed citations
7.
8.
Wright, E. M., et al.. (2016). The Lasting Effects Of Social Media Trends On Advertising. Journal of Business & Economics Research (JBER). 14(3). 75–82. 7 indexed citations
9.
Khanfar, Nile M., et al.. (2015). Banning Tobacco Sales at the Retail Pharmacy: Natural Evolution of Drug Store As Responsible Health Provider Or Effective Marketing Strategy?. Health Marketing Quarterly. 32(4). 382–393. 3 indexed citations
10.
Thomas, Jennifer E., Joshua Caballero, & Catherine Harrington. (2015). The Incidence of Akathisia in the Treatment of Schizophrenia with Aripiprazole, Asenapine and Lurasidone: A Meta-Analysis. Current Neuropharmacology. 13(5). 681–691. 37 indexed citations
11.
Singh‐Franco, Devada, et al.. (2012). The effect of linagliptin on glycaemic control and tolerability in patients with type 2 diabetes mellitus: a systematic review and meta‐analysis. Diabetes Obesity and Metabolism. 14(8). 694–708. 24 indexed citations
12.
Khanfar, Nile M., et al.. (2011). Marketing Retail Health Clinics: Challenges and Controversies Arising From a Health Care Innovation. Health Marketing Quarterly. 28(3). 270–285. 7 indexed citations
13.
Harrington, Catherine, et al.. (2011). Evaluation of Adverse Drug Event Information in US Manufacturer Labels. Current Drug Safety. 6(1). 30–35. 3 indexed citations
14.
Harrington, Catherine & Clayton English. (2011). Adverse Drug Events Related to Ziprasidone: A Meta‐analysis of Randomized, Placebo‐Controlled Trials. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 31(9). 840–849. 5 indexed citations
15.
Khanfar, Nile M., et al.. (2011). The Value of Patient Care in the New Economy. Journal of Management and Strategy. 2(2). 1 indexed citations
16.
Singh‐Franco, Devada, Alexandra Pérez, & Catherine Harrington. (2010). The effect of pramlintide acetate on glycemic control and weight in patients with type 2 diabetes mellitus and in obese patients without diabetes: a systematic review and meta‐analysis. Diabetes Obesity and Metabolism. 13(2). 169–180. 60 indexed citations
17.
Harrington, Catherine & Clayton English. (2010). Tolerability of paliperidone: a meta-analysis of randomized, controlled trials. International Clinical Psychopharmacology. 25(6). 334–341. 26 indexed citations
18.
Abramson, Richard G., et al.. (2004). Generic drug cost containment in Medicaid: lessons from five state MAC programs.. PubMed. 25(3). 25–34. 7 indexed citations
19.
Harrington, Catherine, et al.. (2000). A cost analysis of diabetic lower-extremity ulcers.. Diabetes Care. 23(9). 1333–1338. 192 indexed citations
20.
Rubin, Robert J., et al.. (1999). The Economic Impact of Staphylococcus aureus Infection in New York City Hospitals. Emerging infectious diseases. 5(1). 9–17. 345 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sarah Ramsay Breakdown of academic impact, for papers by Aimin Wang Breakdown of academic impact, for papers by Xing J. Lee Breakdown of academic impact, for papers by Mary E. Walker Breakdown of academic impact, for papers by Linda Cowan Breakdown of academic impact, for papers by Laura Martinengo Breakdown of academic impact, for papers by Soma Wali Breakdown of academic impact, for papers by Friedrich Hofmann Breakdown of academic impact, for papers by Pieter Stolk
Rankless by CCL
2026